Tooth regrowth medicine to begin clinical trial in July 2024 in Japan

A tooth regrowth medicine developed by a Japanese research team is set to head to a clinical trial in July 2024, according to a June 12 report by The Mainichi.

The medicine is intended to be used by individuals who have anodontia, a congenital condition that causes people to not grow a full set of teeth. 

The lead researcher for the team is Katsu Takahashi, who is also the head of the dentistry and oral surgery department at the Medical Research Institute Kitano Hospital in Osaka, Japan. 

The research team hopes to have the medicine ready for general public use in 2030 and will be mostly used to treat children aged 2 to 6, the report said. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.